TD Securities (USA)’s Regeneron Pharmaceuticals REGN Stock Holding History

TD Securities (USA)’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$6K	Buy	18 +1	+6%	+$412	0.05%	172
2015 Q4	$9K	Sell	17 -27	-61%	-$14.6K	0.08%	118
2015 Q3	$20K	Sell	44 -30,489	-100%	-$16.4M	0.18%	122
2015 Q2	$15.6M	Buy	30,533 +4,031	+15%	+$1.97M	0.21%	121
2015 Q1	$12M	Sell	26,502 -1,680	-6%	-$712K	0.18%	137
2014 Q4	$11.6M	Buy	28,182 +2,375	+9%	+$934K	0.17%	147
2014 Q3	$9.3M	Sell	25,807 -2,053	-7%	-$688K	0.15%	165
2014 Q2	$7.87M	Buy	27,860 +2,017	+8%	+$598K	0.13%	194
2014 Q1	$7.76M	Sell	25,843 -1,867	-7%	-$575K	0.14%	184
2013 Q4	$7.63M	Buy	27,710 +1,000	+4%	+$288K	0.13%	195
2013 Q3	$8.36M	Buy	26,710 +666	+3%	+$175K	0.16%	148
2013 Q2	$5.86M	Buy	+26,044	New	+$6.06M	0.12%	207

Other funds holding REGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

TD Securities (USA)'s REGN Position: Q1 2016 in Review

TD Securities (USA) increased its Regeneron Pharmaceuticals (REGN) stake by 5.9% in Q1 2016, buying an estimated $412 and bringing the position to 18 shares worth $6K. The position accounts for 0.05% of the portfolio, ranked #172.

TD Securities (USA) first reported a position in REGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $15.6M in Q2 2015. 550 funds tracked by Wall St. Rank hold REGN as of Q1 2016.

TD Securities (USA) held 18 shares of Regeneron Pharmaceuticals worth $6K as of Q1 2016.
TD Securities (USA) bought 1 Regeneron Pharmaceuticals share in Q1 2016, an estimated $412.
Regeneron Pharmaceuticals made up 0.05% of TD Securities (USA)'s portfolio in Q1 2016, its #172 holding.
TD Securities (USA) first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 12 quarters since.
TD Securities (USA)'s Regeneron Pharmaceuticals position peaked at $15.6M in Q2 2015.
550 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2016.

Based on TD Securities (USA)'s 13F filing for Q1 2016, filed 27 Apr 2016.